Abstract
Background: Hypertension and dyslipidemia are
cardiovascular risk factors that commonly coexist .
Objective : To evaluate the effects of ß - blocker
(Atenolol) , ACE inhibitor (Captopril) calcium Channel
blocker (Nefidipin ) and diuretics on serum lipid profiles .
Method: Thirty untreated hypertensive and 147
hypertensive patient treated with these antihypertensive
drugs, attending different public health clinics in Basrah
pronivce were enrolled in this study .
Serum lipid profile were determined enzymaticaly using kits
from BioMerieux, France .
Result : The study has revealed that ß-blocker do not
significantly affect total cholesterol ( TC ) and LDLcholesterol , but increase significantly triglyceride (TG) and
VLDL – cholesterol and decrease HDL – cholesterol.
Diuretics causes a significant elevation of TG with generally
no significant changes in TC , LDL – cholesterol , VLDL –
cholesterol and HDL-cholesterol. ACE inhibitor and calcium
channel blockers appears to have no significant effect on
plasma lipids .
Conclusion :It may important to measure blood lipid levels
to identify pre-existing hyperlipidemia before starting the
antihypertensive therapy and to select antihypertensive agent
that will not influence the lipid profile or interfere with the
therapy of hyperlipidemi
cardiovascular risk factors that commonly coexist .
Objective : To evaluate the effects of ß - blocker
(Atenolol) , ACE inhibitor (Captopril) calcium Channel
blocker (Nefidipin ) and diuretics on serum lipid profiles .
Method: Thirty untreated hypertensive and 147
hypertensive patient treated with these antihypertensive
drugs, attending different public health clinics in Basrah
pronivce were enrolled in this study .
Serum lipid profile were determined enzymaticaly using kits
from BioMerieux, France .
Result : The study has revealed that ß-blocker do not
significantly affect total cholesterol ( TC ) and LDLcholesterol , but increase significantly triglyceride (TG) and
VLDL – cholesterol and decrease HDL – cholesterol.
Diuretics causes a significant elevation of TG with generally
no significant changes in TC , LDL – cholesterol , VLDL –
cholesterol and HDL-cholesterol. ACE inhibitor and calcium
channel blockers appears to have no significant effect on
plasma lipids .
Conclusion :It may important to measure blood lipid levels
to identify pre-existing hyperlipidemia before starting the
antihypertensive therapy and to select antihypertensive agent
that will not influence the lipid profile or interfere with the
therapy of hyperlipidemi